Myomo, Inc. MYO 深 滬
等待開盤 12-17 09:30:00 美东时间
1.01
+0.010
+1.00%
華盛通- 最 高1.04
- 今 開1.01
- 成交量 27.09万股
- 最 低 0.9906
- 昨 收 1.00
- 總市值 3881.99万
- 52周最高 7.1699
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.711
- 委 比 -2.21%
- 總股本 3843.55万
- 歷史最高 695.88
- 量 比 0.41
- 振 幅 4.94%
- 歷史最低 0.369
- 每 手 1
- 風險率 2.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Myomo Affirms FY2025 Sales Guidance of $40.000M-$42.000M vs $40.188M Est
Myomo (AMEX:MYO) affirms FY2025 sales outlook from $40.000 million-$42.000 million to $40.000 million-$42.000 million vs $40.188 million estimate.
11-11 05:08
Myomo Q3 EPS $(0.09), Inline, Sales $10.091M Beat $9.438M Estimate
Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 200 percent decrease over losses of $(0.03) per share from the same period last year. The company
11-11 05:08
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
A Peek at Myomo's Future Earnings
Myomo (AMEX:MYO) is preparing to release its quarterly earnings on Monday, 2025...
11-08 03:06
Deep Dive Into Supernus Pharmaceuticals Stock: Analyst Perspectives (5 Ratings)
Ratings for Supernus Pharmaceuticals (NASDAQ:SUPN) were provided by 5 analysts ...
10-24 05:02
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
Ascendiant Capital Maintains Buy on Myomo, Lowers Price Target to $10.5
Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $11.5 to $10.5.
09-22 17:57
“三重利好”点燃特斯拉股价情绪！马斯克押宝Optimus机器人量产，这些概念也要爆？
“三重利好”点燃股价情绪！特斯拉两日飙涨14%，马斯克押宝Optimus机器人量产，这些港美股概念公司有望受益？>>
09-15 17:39
Bitcoin Dips Below $110,000 As Ethereum, XRP, Dogecoin Extend Losses
Cryptocurrency markets are trading slightly down as Bitcoin has dipped below the crucial $110,000 mark.
08-26 20:14
